Iridex

IRIXNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$12.120 M

$0.69 -3.51%

Close of 6 Nov 2026

As of 6 Nov 2026, Iridex (IRIX) has a market capitalization of $12.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$52.7M

#2700 by revenue

Earnings

-$4.44M

Loss-making

Shares outstanding

17,564,912

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 26 →

#20Qt ImagingQTI$30.5M
#21iTonicITOC$12.4M
#22IridexIRIX$12.1M
#23ENDRA Life SciencesNDRA$7.30M
#24NuwellisNUWE$1.87M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Iridex, worth $1.53K. Grants and option exercises are excluded.

Romeo R. DizonChief Financial Officer$1.53K
2,354 shares at $0.65 on 14 Sept 2026 · filed 14 Sept 2026

What if Iridex were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,607,573

Per share 2,329,816× higher

Bitcoin $1.53T

$86,982.96

Per share 126,062× higher

Apple $5.02T

$285,556.95

Per share 413,851× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Iridex are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.